Development System
PDCD1_site_12 | SCGE Toolkit
Database of study and experiment data generated by the Somatic Cell Genome Editing Consortium
| A novel human T cell platform to define biological adverse effects of genome editing |
| PDCD1_site_12 |
| Calculated editing efficiency by targeted amplicon deep sequencing |
|
| Editing Efficiency |
| 15000000507 |
|
| SpCas9 |
| P3 Nucleofection Kit |
| Commercial Reagent |
| PDCD1_site_12 |
|
|
| Human |
| CD4/CD8 Human Primary T cell |
|
| Male |
|
| nucleofection |
|
| 75 pmol Cas9 protein; 3-fold molar excess of sgRNA |
|
|
|
|
| ribonucleoprotein (RNP) |
|
|
|
| Measured Values |
| Samples Size: | 3 |
| |
| Mean |
8.28  |
| 1 |
7.93437002571324  |
| 2 |
8.867856281649381  |
| 3 |
8.037592930284749  |
| |
|
| Publication Title |
|
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |